Patent intelligence · US
US 8895078
Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
Patent details — US 8895078
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 25, 2014
- Expiration
- Nov 20, 2034
- Applicant
- BIONORICA ETHICS GMBH
- Claims
- 4
- CPC classes
- A61K, A61K31/35, A61K36/185, A61P
Quick answer
US 8895078 (Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts) is held by BIONORICA ETHICS GMBH. Status: granted. Granted Nov 25, 2014. Expires Nov 20, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIONORICA ETHICS GMBH
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K31/35, A61K36/185, A61P, A61P25/26
More from BIONORICA ETHICS GMBH
Related pharmaceutical patents in our USPTO index.
-
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12239729
TRPV3 agonists for the treatment of skin conditions
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12018043
CD73 inhibitors
granted -
US 12005080
Method for promoting proliferation of immune cells
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11807658
CD73 inhibitors
granted
Frequently asked questions
What is US patent 8895078?
US 8895078 (Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts) is held by BIONORICA ETHICS GMBH. Status: granted. Granted Nov 25, 2014. Expires Nov 20, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8895078?
BIONORICA ETHICS GMBH is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 52 pharmaceutical patents for this assignee.
When does US 8895078 expire?
Our index shows an expiration date of Nov 20, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.